Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes.

Insulin is released in high-frequency pulsatile bursts at intervals of 6-13 min. Intrapancreatic mechanisms are assumed to coordinate pulsatile insulin release, but small oscillations in plasma glucose concentrations may contribute further. To gain additional insight into beta-cell (patho)physiology, we explored the ability of repetitive small glucose infusions (6 mg/kg over 1 min every 10 min) to modify rapid pulsatile insulin secretion in 10 type 2 diabetic individuals (plasma glucose 9.3 +/- 1.0 mmol/l, HbA1c 7.9 +/- 0.5%, mean +/- SE) and 10 healthy subjects. All subjects were investigated twice in randomly assigned order: during saline and during glucose exposure. Blood was collected every minute for 90 min to create a plasma insulin concentration time-series for analysis using 3 complementary algorithms: namely, spectral analysis, autocorrelation analysis, and approximate entropy (ApEn). During saline infusion, none of the algorithms were able to discriminate between diabetic and control subjects (P > 0.20). During glucose entrainment, spectral density peaks (SP) and autocorrelation coefficients (AC) increased significantly (P < 0.001), and ApEn decreased (P < 0.01), indicating more regular insulin time-series in the healthy volunteers. However, no differences were observed in the diabetic individuals between the glucose and saline conditions. Furthermore, in spite of identical absolute glucose excursions (approximately 0.3 mmol/l) glucose pulse entrainment led to a complete (SP: 4.76 +/- 0.62 [range 2.08-7.60] vs. 17.24 +/- 0.93 [11.70-20.58], P < 0.001; AC: 0.01 +/- 0.05 [0.33-0.24] vs. 0.64 +/- 0.05 [0.35-0.83], P < 0.001) or almost complete (ApEn: 1.59 +/- 0.02 [1.48-1.67] vs. 1.42 +/- 0.05 [1.26-1.74], P < 0.005) separation of the insulin time-series in diabetic and control subjects. Even elevating the glucose infusion rate in the diabetic subjects to achieve comparable relative (and hence higher absolute) glucose excursions (approximately 4.9%) failed to entrain pulsatile insulin secretion in this group. In conclusion, the present study demonstrates that failure to respond adequately with regular oscillatory insulin secretion to recurrent high-frequency and (near)-physiological glucose excursion is a manifest feature of beta-cell malfunction in type 2 diabetes. Whether the model will be useful in unmasking subtle (possible prediabetic) defects in beta-cell sensitivity to glucose drive remains to be determined.

[1]  S M Pincus,et al.  Approximate entropy as a measure of system complexity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. J. Goodner,et al.  Synchronous, sustained oscillation of C-peptide and insulin in the plasma of fasting monkeys. , 1978, Endocrinology.

[3]  R. Turner,et al.  Brief, Irregular Oscillations of Basal Plasma Insulin and Glucose Concentrations in Diabetic Man , 1981, Diabetes.

[4]  J. Sturis,et al.  Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus. , 1993, The Journal of clinical investigation.

[5]  G. Dailey,et al.  Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. , 1995, JAMA.

[6]  M. Vorgerd,et al.  Deficiency of phosphofructo-1-kinase/muscle subtype in humans impairs insulin secretion and causes insulin resistance. , 1997, The Journal of clinical investigation.

[7]  M. Byrne,et al.  Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance. , 1998, Diabetes.

[8]  J. Soler,et al.  Beta‐cell Dysfunction in First‐degree Relatives of Patients with Non‐insulin‐dependent Diabetes Mellitus , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[9]  G. Brandenberger,et al.  Ultradian oscillations of plasma glucose, insulin, and C-peptide in man during continuous enteral nutrition. , 1987, The Journal of clinical endocrinology and metabolism.

[10]  M. Byrne,et al.  Glucagon-Like Peptide 1 Improves the Ability of the β-Cell to Sense and Respond to Glucose in Subjects With Impaired Glucose Tolerance , 1998, Diabetes.

[11]  N. Porksen,et al.  In humans at least 75% of insulin secretion arises from punctuated insulin secretory bursts. , 1997, American journal of physiology. Endocrinology and metabolism.

[12]  J D Veldhuis,et al.  Females secrete growth hormone with more process irregularity than males in both humans and rats. , 1996, The American journal of physiology.

[13]  S. O’Rahilly,et al.  Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. , 1988, The New England journal of medicine.

[14]  J. Sturis,et al.  Alterations in pulsatile insulin secretion in the Zucker diabetic fatty rat. , 1994, The American journal of physiology.

[15]  E. Ipp,et al.  Pulsatile Insulin Secretion in Isolated Rat Islets , 1990, Diabetes.

[16]  J. Sturis,et al.  Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone. , 1996, The American journal of physiology.

[17]  K. Tornheim.  Are Metabolic Oscillations Responsible for Normal Oscillatory Insulin Secretion? , 1997, Diabetes.

[18]  R. Turner,et al.  Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. , 1979, The New England journal of medicine.

[19]  E. Samols,et al.  Role of intrapancreatic ganglia in regulation of periodic insular secretions. , 1985, The American journal of physiology.

[20]  Steven M. Pincus,et al.  Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  N. Porksen,et al.  Pulsatile insulin secretion accounts for 70% of total insulin secretion during fasting. , 1995, The American journal of physiology.

[22]  J. Sturis,et al.  Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. , 1996, The New England journal of medicine.

[23]  C. J. Goodner,et al.  Insulin, glucagon, and glucose exhibit synchronous, sustained oscillations in fasting monkeys. , 1977, Science.

[24]  Steven M. Pincus,et al.  Concordant induction of rapid in vivo pulsatile insulin secretion by recurrent punctuated glucose infusions. , 2000, American journal of physiology. Endocrinology and metabolism.

[25]  A. Vaag,et al.  Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. , 1995, The Journal of clinical investigation.

[26]  J D Veldhuis,et al.  Disorderly and nonstationary insulin secretion in relatives of patients with NIDDM. , 1997, The American journal of physiology.

[27]  C. S. Mao,et al.  Glucose entrainment of high-frequency plasma insulin oscillations in control and type 2 diabetic subjects. , 1999, Diabetes.

[28]  M. Byrne,et al.  Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. , 1995, The Journal of clinical investigation.

[29]  M. Byrne,et al.  Elevated plasma glucose 2 h postchallenge predicts defects in beta-cell function. , 1996, The American journal of physiology.

[30]  L. Groop,et al.  Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. , 1994, The Journal of clinical investigation.

[31]  K. Polonsky,et al.  Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. , 1988, The Journal of clinical investigation.

[32]  G. Weir,et al.  Sustained oscillations of insulin, glucagon, and somatostatin from the isolated canine pancreas during exposure to a constant glucose concentration. , 1980, The Journal of clinical investigation.

[33]  M. Røder,et al.  Enzyme immunoassay for intact human insulin in serum or plasma. , 1993, Clinical chemistry.

[34]  R. Wolfe,et al.  Rapid oscillations in plasma insulin, glucagon, and glucose in obese and normal weight humans. , 1982, The Journal of clinical endocrinology and metabolism.

[35]  J. Holst,et al.  Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations , 1999, Diabetologia.